Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).
推出的年份: 1992
副标题
树号: E02.095.465.425.750, E02.186.750, E02.815.520
MeSH 单一 ID: D016499
进入的组:
Radioimmunotherapies
Immunoradiotherapy
Immunoradiotherapies
早前的内容:
Antibodies, Monoclonal/therapeutic use (1984-1991)
留言 (0)